VVV: We Are Removing Valvoline from Investing Ideas

10/11/19 11:00AM EDT

A quick note from Hedgeye CEO Keith McCullough:

This is the same top-down macro market timing reason as Tenet Healthcare (THC). In addition to HIGH BETA, SMALL CAP is a Factor Exposure The Machine will not like being long of during #Quad4 in Q3 EPS #slowing season.

*There is no change to Retail analyst Brian McGough's fundamental long thesis on Valvoline (VVV).

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.